Acquisition Overview - Parker Hannifin Corporation is acquiring Filtration Group Corporation [1] - The transaction consideration is $9.25 billion on a cash-free, debt-free basis [10] - The acquisition is expected to close within six to twelve months [10] Financial Impact and Synergies - Filtration Group is expected to have $2 billion in sales in CY2025 with a 23.5% adjusted EBITDA margin [9, 10] - The acquisition is expected to be accretive to organic growth, synergized EBITDA margin, adjusted EPS, and cash flow [9, 10] - $220 million of cost synergies are expected by the end of year three, leveraging "The Win Strategy" [9, 10, 19] - The company is targeting >30% adjusted EBITDA margin expected by end of year three [10] Market Expansion and Portfolio Transformation - The acquisition expands Parker's presence in Life Sciences (28%), HVAC/R (23%), and In-Plant & Industrial (20%) market verticals [9, 12] - It increases Parker Filtration aftermarket sales by 500 bps [9, 13] - Post-acquisition, the proforma FY26 sales are estimated to be ~$23 billion [21]

Core Insights - Parker Hannifin Corporation has announced a definitive agreement to acquire Filtration Group Corporation for a cash purchase price of $9.25 billion, which equates to 19.6 times Filtration Group's estimated adjusted EBITDA for 2025, or 13.4 times when including expected cost synergies [1][3] - The acquisition is expected to close within six to twelve months, pending customary closing conditions and regulatory approvals [1][3] Company Overview - Filtration Group is a U.S.-based private company that specializes in filtration technologies, generating approximately 85% of its sales from the aftermarket, which provides strong recurring revenue streams [2][7] - The company anticipates sales of $2 billion for the calendar year 2025, with an adjusted EBITDA margin of 23.5% [2][7] Strategic Rationale - The acquisition aims to create one of the largest global industrial filtration businesses, enhancing Parker's ability to serve customers globally with complementary capabilities and a strong aftermarket presence [3][7] - Parker expects to achieve pre-tax cost synergies of approximately $220 million by the end of year three post-transaction, leveraging its business system, The Win Strategy™ [3][7] Financial Impact - The transaction is projected to be accretive to Parker's organic growth, synergized EBITDA margin, adjusted EPS, and cash flow, with an expected high single-digit cash return on invested capital (ROIC) by year five [3][7] - Filtration Group's expected adjusted EBITDA, including anticipated cost synergies, is projected to reach $693 million by the end of year three [13]

Thermo Fisher Scientific Inc. (NYSE:TMO) is among the undervalued wide moat stocks to buy now. On Tuesday, Thermo Fisher Scientific Inc. (NYSE:TMO) announced the completion of its acquisition of Solventum Corporation’s purification and filtration business. This $4.0 billion transaction is aimed at expanding the company’s bioprocessing and adjacent market offerings. While providing growth and synergy opportunities, this acquisition is anticipated to generate $750 million in revenue for 2025. Not only that, ...